Jason Hulse Murray Sells 317 Shares of PACS Group (NYSE:PACS) Stock

PACS Group, Inc. (NYSE:PACSGet Free Report) CEO Jason Murray sold 317 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51. Following the completion of the sale, the chief executive officer owned 54,555,249 shares of the company’s stock, valued at approximately $2,456,622,862.47. This trade represents a 0.00% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

  • On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The stock was sold at an average price of $45.23, for a total transaction of $476,226.67.
  • On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total transaction of $396,098.36.
  • On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The shares were sold at an average price of $43.33, for a total transaction of $206,164.14.
  • On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The shares were sold at an average price of $43.49, for a total value of $1,046,238.93.
  • On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total value of $984,943.68.
  • On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The shares were sold at an average price of $42.56, for a total value of $858,562.88.
  • On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The shares were sold at an average price of $42.94, for a total transaction of $1,021,242.02.
  • On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total transaction of $1,024,015.23.
  • On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The stock was sold at an average price of $43.90, for a total value of $2,600,811.60.
  • On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The shares were sold at an average price of $43.92, for a total transaction of $4,010,159.52.

PACS Group Stock Down 0.3%

Shares of PACS stock traded down $0.15 on Monday, hitting $44.61. The company’s stock had a trading volume of 759,862 shares, compared to its average volume of 904,574. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91. PACS Group, Inc. has a fifty-two week low of $9.69 and a fifty-two week high of $49.49. The firm’s fifty day moving average price is $44.74 and its 200-day moving average price is $39.08. The stock has a market capitalization of $7.06 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 1.40 and a beta of -0.13.

PACS Group (NYSE:PACSGet Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%.The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Research analysts anticipate that PACS Group, Inc. will post 2.13 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on PACS. Weiss Ratings lowered shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, August 5th. Oppenheimer upped their price objective on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, JPMorgan Chase & Co. boosted their target price on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $58.80.

Read Our Latest Stock Analysis on PACS

Institutional Trading of PACS Group

Several institutional investors have recently modified their holdings of the company. Financial Management Professionals Inc. raised its stake in PACS Group by 54.9% during the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of PACS Group by 127.0% in the 4th quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock valued at $42,000 after purchasing an additional 612 shares in the last quarter. KBC Group NV acquired a new stake in shares of PACS Group in the 1st quarter valued at $42,000. Western Wealth Management LLC bought a new stake in shares of PACS Group in the 1st quarter worth about $48,000. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of PACS Group in the 2nd quarter worth about $75,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.

Further Reading

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.